FDA Approved: WEGOVY — Original Application (Novo Nordisk)

View source ↗

Summary

This FDA entry covers Novo Nordisk's original application for Wegovy (semaglutide). Wegovy is a GLP-1 receptor agonist approved for chronic weight management in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• WEGOVY (Semaglutide)

Snippet

ORIG AP for WEGOVY (SEMAGLUTIDE)